Value proposition

Multiomics research for precision medicines

Platinum Discovery offers a cutting-edge Tumour-to-Target Platform, specialising in cancer vaccine development through the identification of tumour-specific neoantigens. We provide a comprehensive, end-to-end drug discovery pipeline, supporting clinical trial research and translational science for patient samples.

Our multidisciplinary team brings together expertise in biology, clinical sciences, multi-omics technologies, bioinformatics, and computational sciences, enabling a deep understanding of the biological processes critical to drug development. We excel at integrating diverse scientific domains to deliver holistic, innovative solutions.

With extensive experience in designing and managing complex research programmes, we assemble tailored teams of experts, drawing on our network of consultants and partners, including the renowned University of Dundee’s School of Life Sciences. This ensures access to cutting-edge lab skills, clinical insight, and advanced informatics tools, including proprietary software developed in-house.

Platinum Discovery is pioneering advancements in neoantigen discovery, laying the groundwork for the next generation of cancer vaccines.


Proteomics, Immunopeptidomics, and Cancer Vaccine Development